Notice of System Recovery: System maintenance has been completed. We deeply apologize for the inconvenience caused by exceeding the scheduled completion time.
Product Document Searching Made Easy by 2D Code! | TCI Chemistry News July 2025 | [Product Highlights] Travoprost with Intra-Ocular-... | Various analytical charts can be searched on each product detail page and Product Document Search (The kinds of analytical charts differ by product)
Maximum quantity allowed is 999
请选择数量
CAS RN: 236395-14-5 | 產品號碼: E1046
Eslicarbazepine Acetate
×
![]()
×
* 以上價格已含運費關稅等但一些需要海運以及乾冰運輸的產品除外,詳情請與
當地經銷商
洽詢。
* TCI會時常優化儲存條件,儲存溫度請以在線目錄為準，敬請留意。
| 產品號碼 | E1046 |
純度/分析方法 
|
>98.0%(HPLC)(N) |
| 分子式 / 分子量 | C__1__7H__1__6N__2O__3 = 296.33 |
| 外觀與形狀（20°C） | Solid |
| 儲存條件
|
Refrigerated (0-10°C) |
| 應避免的情況 | Heat Sensitive |
| 包裝和容器
|
1G-Glass Bottle with Plastic Insert （閲覽圖片）, 200MG-Glass Bottle with Plastic Insert （閲覽圖片） |
| CAS RN | 236395-14-5 |
| Reaxys-RN | 8336447 |
| PubChem Substance ID | 253662249 |
| MDL編號 | MFCD06798333 |
產品規格
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(with Total Nitrogen) | min. 98.0 % |
| Melting point | 185.0 to 189.0 °C |
| Specific rotation [a]20/D | -20.0 to -24.0 deg(C=1, Pyridine) |
性質
| 熔點 | 187 °C |
| 比旋光 [α]D | -22° (C=1,Pyridine) |
GHS
| 圖形表示 |
|
| 信號詞 | Warning |
| 危險性說明 | H336 : May cause drowsiness or dizziness. |
| 防範說明 | P501 : Dispose of contents/ container to an approved waste disposal plant. P261 : Avoid breathing dust/ fume/ gas/ mist/ vapors/ spray. P271 : Use only outdoors or in a well-ventilated area. P304 + P340 + P312 : IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER/doctor if you feel unwell. P403 + P233 : Store in a well-ventilated place. Keep container tightly closed. P405 : Store locked up. |
相關法規
運輸資料
| HS編碼* | 2933.99-000 |
Application
Romifidine: a potent and selective α2-adrenoceptor agonist
Eslicarbazepine acetate (BIA 2-093 or ESL) is a central nervous system (CNS)-active compound with anticonvulsant activity. BIA 2-093 has voltage-gated sodium channel (VGSC) blocking property. BIA 2-093 is metabolized to eslicarbazepine (S-licarbazepine), an active metabolite of oxcarbazepine [O0363], which is responsible for pharmacological activity. BIA 2-093 is used as a third generation antiepileptic drugs (AEDs), and is often used in combination with the other AEDs. (The product is for research purpose only.)
References
- Anticonvulsant and sodium channel-blocking properties of novel 10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide derivatives
- Metabolism of two new antiepileptic drugs and their principal metabolites S(+)- and R(-)-10,11-dihydro-10-hydroxy carbamazepine
- Enantioselective HPLC-UV method for determination of eslicarbazepine acetate (BIA 2-093) and its metabolites in human plasma
- Eslicarbazepine acetate (BIA 2-093) (a review)
- Drug interactions involving the new second- and third-generation antiepileptic drugs (a review)
考研文獻
產品介紹報導
產品文件 （部分產品的分析圖譜無法提供，敬請諒解。）
SDS
請選擇語言。
請求的SDS不可用。
如需更多幫助，請聯繫我們 。
產品規格
檢驗報告(CoA)及其他文檔
請輸入批號
輸入的批號不正確
示例 CoA
可下載CoA示例。注：該示例可能非最新批次的CoA。
目前沒有該產品的 CoA 示例。
分析圖譜
請輸入批號
輸入的批號不正確
很抱歉，您搜索的分析圖譜無法提供。